Teladoc Health Inc vs Twilio Inc — how do they compare? Teladoc Health Inc trades at $5.77 (market cap $1.01B), while Twilio Inc trades at $289.47 (market cap $42.35B). The key difference: Twilio Inc is far larger — about 41.9× Teladoc Health Inc's market cap, and Twilio Inc is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and Twilio Inc for 56 Days on average.
| TDOC | TWLO | |
|---|---|---|
Market Cap | $1.01B | $42.35B |
Volume | 4,668,477 | 1,862,642 |
Sector | Health | Technology |
52-Week High | $9.72 | $301.27 |
52-Week Low | $4.47 | $106.23 |
Typical Hold Time | 39 Days | 56 Days |
Enterprise Value | $1.27B | $40.76B |
Signals from Pluang's Aura AI — not financial advice
Teladoc Health (TDOC) trades at $5.54, down 0.36% on the day, as the stock faces bearish technical momentum despite recent earnings beats. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net income margin in 2026. Analyst sentiment is mixed with 35.7% buy ratings but a consensus price target of $8.83 suggesting 59% upside potential. Recent CFO appointment and legal officer transitions signal management changes amid ongoing operational challenges.
TDOC presents a high-risk opportunity with significant valuation discount (P/S 0.4x) but faces persistent profitability challenges. The integrated care business shows promise with improving margins, while BetterHelp weakness and negative cash flow in 2025 raise concerns. Upside depends on successful execution of turnaround strategy and achieving sustainable profitability in the competitive telehealth market.
Twilio (TWLO) trades at $275.77, up 1.01% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company has shown strong revenue growth, reaching $5.07B in 2025, and a significant improvement in net income to $33.83M. Recent news highlights its upcoming inclusion in the S&P 500 index, reflecting increased market recognition and institutional interest.
Outlook is positive with accelerating revenue growth and profitability, supported by AI-driven communication services. Key risks include high valuation multiples and competitive pressures. Analyst consensus is bullish with a 76.92% buy rating, though price targets suggest near-term consolidation potential from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →